First-trimester treatment of fetal anemia secondary to parvovirus B19 infection.
Here we report two cases of first-trimester parvovirus B19 (PV-B19) infection that were successfully treated by intrauterine blood transfusion into the umbilical vein. At 13 weeks' gestation both fetuses presented with increased nuchal translucency (NT) and cardiomegaly. In both cases pulsed Doppler ultrasound examination of the fetal middle cerebral artery (MCA) revealed increased peak systolic velocity (PSV), which led to a suspicion of fetal anemia. Maternal PV infection was confirmed by a positive polymerase chain reaction result. Each fetus received a 3-mL intravenous transfusion of packed red blood cells into the umbilical vein, using a 25-G spinal needle. Follow-up ultrasound and Doppler examination demonstrated fetal well-being, decline of the MCA-PSV and resolution of the NT. Case 1 was readmitted at 25 weeks' gestation with severe hydrops fetalis, and both mother and fetus still tested positive for PV-B19 DNA. Three more intrauterine blood transfusions were performed and the fetal hydrops resolved. In Case 2 no additional transfusions were needed. Both babies had a good neonatal outcome and uneventful follow-up. Our findings demonstrate that the MCA-PSV is helpful in establishing the diagnosis of first-trimester fetal anemia. Intravasal transfusion can be attempted as early as the first trimester.
Kempe
A
A
Department of Obstetrics and Prenatal Medicine, University Hospital of Bonn, Germany. andrea.kempe@ukb.uni-bonn.de
Rösing
B
B
Berg
C
C
Kamil
D
D
Heep
A
A
Gembruch
U
U
Geipel
A
A
D000328:Adult; D000740:Anemia / Q000000981:diagnostic imaging / Q000628:therapy* / Q000821:virology; D001805:Blood Transfusion, Intrauterine / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015160:Hydrops Fetalis / Q000000981:diagnostic imaging / Q000628:therapy* / Q000821:virology; D018445:Infectious Disease Transmission, Vertical; D010322:Parvoviridae Infections / Q000628:therapy* / Q000635:transmission; D016732:Parvovirus B19, Human; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy*; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D011295:Prenatal Care / Q000379:methods; D016896:Treatment Outcome; D016216:Ultrasonography, Prenatal